CHEMOMAB THERAPEUTICS LTD

CUSIP: 16385C104 Class: SPONSORED ADS

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 213,052 Value ($000) $247 Avg Close — Range —
Q1 2025
Shares 213,052 Value ($000) $232 Avg Close — Range —
Q4 2024
Shares 213,052 Value ($000) $386 Avg Close — Range —
Q3 2024
Shares 213,392 Value ($000) $335 Avg Close — Range —
Q2 2024
Shares 213,392 Value ($000) $196 Avg Close — Range —
Q1 2024
Shares 213,392 Value ($000) $166 Avg Close — Range —
Q4 2023
Shares 213,392 Value ($000) $109 Avg Close — Range —
Q3 2023
Shares 213,392 Value ($000) $191 Avg Close — Range —
Q2 2023
Shares 213,392 Value ($000) $280 Avg Close — Range —
Q1 2023
Shares 236,709 Value ($000) $342 Avg Close — Range —
Q4 2022
Shares 313,392 Value ($000) $1,003 Avg Close — Range —
Q3 2022
Shares 245,896 Value ($000) $612 Avg Close — Range —
Q2 2022
Shares 268,104 Value ($000) $992 Avg Close — Range —
Q1 2022
Shares 268,104 Value ($000) $1,292 Avg Close — Range —
Q4 2021
Shares 265,264 Value ($000) $1,829 Avg Close — Range —
Q3 2021
Shares 285,264 Value ($000) $3,160 Avg Close — Range —
Q2 2021
Shares 290,534 Value ($000) $5,526 Avg Close — Range —